These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8381342)

  • 41. FDA Advisory Committee stalemates on delavirdine.
    AIDS Patient Care STDS; 1997 Apr; 11(2):96-7. PubMed ID: 11361773
    [No Abstract]   [Full Text] [Related]  

  • 42. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex.
    Dudley MN; Graham KK; Kaul S; Geletko S; Dunkle L; Browne M; Mayer K
    J Infect Dis; 1992 Sep; 166(3):480-5. PubMed ID: 1323615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FDA notifications. FDA approved 3 generic formulations of stavudine.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951
    [No Abstract]   [Full Text] [Related]  

  • 45. FDA clearance for ritonavir in children with AIDS.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361797
    [No Abstract]   [Full Text] [Related]  

  • 46. DOXIL approved by FDA.
    AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
    [No Abstract]   [Full Text] [Related]  

  • 47. FDA reform: activists' proposals. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Aug; (no 228):6-8. PubMed ID: 11362628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Europe learns from US drug mistakes.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1996 Mar; 2(3):39. PubMed ID: 11363346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glaxo's antiviral ills not deemed contagious.
    Dove A
    Nat Biotechnol; 1999 Apr; 17(4):322-3. PubMed ID: 10207869
    [No Abstract]   [Full Text] [Related]  

  • 50. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Policy of the Health Ministry on anti-retroviral therapy].
    del Bianco R
    Rev Soc Bras Med Trop; 1995; 28 Suppl 2():18-22. PubMed ID: 8693145
    [No Abstract]   [Full Text] [Related]  

  • 52. New CMV retinitis drug approved.
    Body Posit; 1998 Oct; 11(10):10. PubMed ID: 11365907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studying new drugs for HCV. Excerpts from the FDA hearing.
    Huff B
    GMHC Treat Issues; 2006; 20(8-12):11-4. PubMed ID: 17569164
    [No Abstract]   [Full Text] [Related]  

  • 54. FDA panel backs Glaxo Wellcome drug for use in treating chronic hepatitis B. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1998; ():32. PubMed ID: 11367504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FDA's meeting of Antiviral Drugs Advisory Committee.
    AIDS Alert; 2006 Oct; 21(10):118-9. PubMed ID: 17063593
    [No Abstract]   [Full Text] [Related]  

  • 56. The fast track: federal agencies and the political demand for AIDS drugs.
    Foreman CH
    Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828
    [No Abstract]   [Full Text] [Related]  

  • 57. FDA notifications. FDA grants tentative approval to two ART drugs under expedited review.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580369
    [No Abstract]   [Full Text] [Related]  

  • 58. Hopeful CMV drug stalled.
    Proj Inf Perspect; 1997 Jul; (22):13. PubMed ID: 11364570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nevirapine approved.
    AIDS Patient Care STDS; 1996 Dec; 10(6):378. PubMed ID: 11361568
    [No Abstract]   [Full Text] [Related]  

  • 60. Federal AIDS policy issues today.
    James JS
    AIDS Treat News; 1997 Aug; (No 276):2-8. PubMed ID: 11364520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.